The Phase 3 trial of another investigational coronavirus disease 2019 (COVID-19) vaccine has begun enrolling adult volunteers. The randomized, placebo-controlled…
Read More
Moderna Announces Publication in The New England Journal of Medicine of Interim Results From Older Adult Age Cohorts in Phase 1 Study of its mRNA Vaccine Against COVID-19 (mRNA-1273)
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Sep. 29, 2020– Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create…
Read More
Alternative to the condom: The pill for the man to test phase – to-Video
Researchers have tested a new potential contraceptive for men. The pill for men has proved to be a real Alternative….
Read More
Vaxart Announces Initiation of Bivalent Norovirus Vaccine Phase 1b Clinical Trial
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Mar. 19, 2019– Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered…
Read More
vTv Therapeutics Announces Publication of Comprehensive Data in Science Translational Medicine Detailing the Discovery and Clinical Development of TTP399, including Results of Phase 2 AGATA Study
HIGH POINT, N.C.–(BUSINESS WIRE)–Jan. 16, 2019– vTv Therapeutics Inc. (Nasdaq: VTVT) today announced the publication of a paper in Science…
Read More
Pulmatrix Announces Positive Final Results from the Phase 1/1b Clinical Trial of Pulmazole – an Inhaled Dry-Powder iSPERSE™ Formulation of Itraconazole
LEXINGTON, Mass., Nov. 21, 2018 /PRNewswire/ — Pulmatrix, Inc. (NASDAQ: PULM) announced the results of the completed first-in-human study of…
Read More